NCT04582682

Brief Summary

The purpose of this study is to identify changes in salivary micro ribonucleic acid (miRNA) levels that are predictive of symptom duration and character following mild traumatic brain injury (mTBI) in children.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
750

participants targeted

Target at P75+ for all trials

Timeline
0mo left

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

5 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Jan 2021Jun 2026

First Submitted

Initial submission to the registry

September 24, 2020

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 9, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

January 18, 2021

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

March 11, 2026

Status Verified

February 1, 2026

Enrollment Period

4.8 years

First QC Date

September 24, 2020

Last Update Submit

March 9, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Presence or absence of persistent post-concussive symptoms (PPCS) 30 days after injury

    PPCS will be defined by persistence of at least 3 symptoms on day 30, compared with pre-injury state, which will be determined from pre-injury symptoms reported at enrollment using the Post-Concussion Symptom Inventory (PCSI). PCSI is a self reported survey that focus on symptoms in the cognitive, emotional, sleep, and physical domains. This form is called the "Sport Concussion Assessment Tool- 5th Edition" and symptoms are scored from 0 to 6 with 0 being no symptom and 6 being severe. A high score is indicative of a subject experiencing the worst they have experienced this symptom.

    30 days after injury

  • Presence or absence of concussion recovery 30 days after injury

    Defined as a score of 0 (no difference) on item 22 of the Post-Concussion Symptom Inventory (PCSI); "To what degree do you feel 'differently' than before your injury?" This patient-oriented outcome measure relies on the individual's experience of symptoms to define recovery.PCSI is a self reported survey that focus on symptoms in the cognitive, emotional, sleep, and physical domains. This form is called the "Sport Concussion Assessment Tool- 5th Edition" and symptoms are scored from 0 to 6 with 0 being no symptom and 6 being severe.

    30 days after injury

Secondary Outcomes (3)

  • Concussion symptom burden and severity

    Within 48 hours of injury, 7 days post-injury, and 30 days post-injury

  • Orientation, immediate memory, concentration, and delayed recall performance

    Within 48 hours of injury

  • Balance performance

    Within 48 hours of injury

Eligibility Criteria

Age13 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children 13-18 years with mild traumatic brain injury

You may qualify if:

  • Presence of mTBI: defined by criteria from the Berlin Consensus Statement and WHO. Assessment for mTBI status be performed by a licensed clinician per the 2018 CDC guidelines.
  • Age at enrollment: 13-18 years of age (inclusive).

You may not qualify if:

  • \> 48 hours after initial mTBI
  • Glasgow Coma Scale score of 13 or less
  • Previous moderate-to-severe TBI requiring overnight hospitalization
  • Unresolved symptoms from previous concussion, or any concussion within the last 3 months
  • Abbreviated Injury Scale (AIS) score \> 3 (to reduce confounding from poly-trauma)
  • Psychiatric illness requiring previous hospitalization;
  • Neurological condition (e.g. epilepsy, hydrocephalus) or abnormality on neuroimaging (if performed)
  • Intellectual disability that prevents ability to provide informed assent
  • Pregnancy
  • Active substance use/dependence
  • Previous neurosurgery
  • Non-fluency in English
  • Upper respiratory infection
  • Periodontal infection
  • Injury to the oropharynx
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Boston Children's Hosptial

Boston, Massachusetts, 02115, United States

Location

Weill Cornell Medicine/ New York Presbyterian Hospital

New York, New York, 10021, United States

Location

SUNY Upstate Medical University

Syracuse, New York, 13210, United States

Location

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229, United States

Location

Penn State Milton S. Hershey Medical Center

Hershey, Pennsylvania, 17033, United States

Location

MeSH Terms

Conditions

Brain Concussion

Condition Hierarchy (Ancestors)

Brain Injuries, TraumaticBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemHead Injuries, ClosedWounds and InjuriesWounds, Nonpenetrating

Study Officials

  • Steve Hicks, MD, PhD

    Penn State University, College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Pediatrics

Study Record Dates

First Submitted

September 24, 2020

First Posted

October 9, 2020

Study Start

January 18, 2021

Primary Completion

November 1, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

March 11, 2026

Record last verified: 2026-02

Locations